Skip to main content
  • Home
  • Digital Diagnostics
Institutional profile

Digital Diagnostics

Digital Diagnostics is an important AI-enabled diagnostics company known for autonomous diagnostic systems, especially in diabetic eye disease screening. Its platform is designed to allow diagnostic assessment in non-specialist settings, reducing dependence on specialist availability for selected screening tasks.

  • Highest 2026 tier: Tier II
  • AI-Enabled Diagnostics Providers
  • 1 ranking category

Overview

Digital Diagnostics is an important AI-enabled diagnostics company known for autonomous diagnostic systems, especially in diabetic eye disease screening. Its platform is designed to allow diagnostic assessment in non-specialist settings, reducing dependence on specialist availability for selected screening tasks.

The company’s relevance lies in autonomous AI. Many AI tools assist clinicians, but Digital Diagnostics has pursued systems that can produce diagnostic outputs within defined use cases. This model is particularly important for chronic disease screening, where specialist shortages can limit access.

Digital Diagnostics is included in 1 2026 ranking category. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.

Firm facts

Public identityDigital Diagnostics
Founded2010
Institution typeAI-Enabled Diagnostics Providers institution
HeadquartersCoralville, United States
Primary focusAI-Enabled Diagnostics Providers
Highest 2026 ranking tierTier II

Principal activities

The company’s relevance lies in autonomous AI. Many AI tools assist clinicians, but Digital Diagnostics has pursued systems that can produce diagnostic outputs within defined use cases. This model is particularly important for chronic disease screening, where specialist shortages can limit access.

Core capability

AI-Enabled Diagnostics Providers

Client relevance

Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.

Execution and verification

Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.

Sector and mandate coverage

Primary category

AI-Enabled Diagnostics Providers

Institutional context

Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.

Market position

Its focus on diabetic retinopathy and related eye disease screening supports broader healthcare goals around early detection, primary care integration, and preventable vision loss.

Digital Diagnostics is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.

Competitive context

The relevant peer set varies by category, geography, client segment and mandate. Digital Diagnostics should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.

Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.

Leadership and governance

Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.

Corporate and public information

The public-facing organization is identified here as Digital Diagnostics. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.

Corporate and disclosure information
OrganizationDigital Diagnostics
HeadquartersCoralville, United States
Verification noteConfirm legal entity, licenses, offices and engagement terms directly before appointment or use.

Rankings and recognition

2026

Tier II

Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.

Related Economy analysis

Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:

Sources and data transparency

Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.

  1. Healthcare Ranking — Top 30 AI-Enabled Diagnostics Providers 2026 — 2026 inclusion and tier classification.
  2. The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
  3. The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
  4. The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.

First published: 29 August 2026

Last substantively reviewed: 29 August 2026

Profile scope: AI-Enabled Diagnostics Providers

This profile has been compiled from publicly available institutional and editorial sources. The profiled organization does not determine its inclusion, editorial characterization or ranking status. Corrections supported by authoritative documentation may be submitted to The Economy Wiki.